Top Markets
Coin of the day
Boston Scientific Corporation Boston Scientific Corporation

Boston Scientific Corporation

BSX
株式のランク #340
Boston Scientific Corporation (BSX) operates as a global leader in medical... Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.
株価
$48.86
時価総額
$72.62B
変化(1日)
1.69%
変化(1年)
-54.20%
US
取引 Boston Scientific Corporation (BSX)

カテゴリー

Boston Scientific Corporation(BSX)のP/E比率
September 2026 時点のP/E比率 TTM 19.48
Boston Scientific Corporation の最新の財務報告および株価によると、現在の P/E (TTM) は 19.48 です。2024 年末時点での P/E は 70.89 でした。
Boston Scientific Corporation の P/E 比率の履歴(2000 〜 2026)
各年末のP/E比率
P/E比率 変化
2026 (TTM) 19.48 -60.18%
2025 48.91 -31.01%
2024 70.89 34.45%
2023 52.73 -44.39%
2022 94.83 63.23%
2021 58.10 -109.35%
2020 -621.10 -4,739.24%
2019 13.39 -54.16%
2018 29.21 -91.06%
2017 326.58 285.92%
2016 84.63 -182.61%
2015 -102.44 -30.52%
2014 -147.45 10.67%
2013 -133.23 6,624.20%
2012 -1.98 -110.84%
2011 18.28 -269.40%
2010 -10.79 -18.52%
2009 -13.24 132.42%
2008 -5.70 -83.69%
2007 -34.93 471.06%
2006 -6.12 -118.98%
2005 32.22 15.12%
2004 27.99 -56.60%
2003 64.49 39.54%
2002 46.22 -124.91%
2001 -185.54 -1,347.09%
2000 14.88 0.00%
類似企業や競合他社のP/E比率
企業 P/E比率 P/E比率の差
35.48 82.19%
US
33.28 70.87%
US
21.39 9.82%
IE
52.16 167.79%
US
- -
DE
P/E比率の読み方

株価収益率(P/E Ratio)は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の(0に近い)P/Eは、損失が大きいことを示します。

P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。

10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。